PB1884: ENGAGING INNATE IMMUNITY: A PHASE 1 DOSE ESCALATION STUDY TO ASSESS SAFETY AND TOLERABILITY OF AFM28 MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)

ABSTRACT:

SUBMITTER: Arnan M 

PROVIDER: S-EPMC10430174 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature